The Role of Anti-Tumor Necrosis Factor Receptor Agents in Cancer Survivors: Does the Risk Justify the Benefit?

Paul Chapman, Lee Cranmer, W. G. Dixon, K. L. Hyrich, John R. Patterson, D. P M Symmons, Mary Toporcer, Michael J. Mastrangelo

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish
    Pages (from-to)11-19
    Number of pages8
    JournalSeminars in Oncology
    Issue number1
    Publication statusPublished - Feb 2010

    Cite this